Kolon Life Science’s Invossa Inj to achieve 1,500 procedures

Published: 2018-08-08 18:20:59

Updated: 2018-08-08 18:20:59

Kolon Life Science(CEO Woo-Seok Lee) announced they acquired approval of Invossa on July 2017, started to sell the product on November and achieved more than 1,500 procedures to July 2018 for 9 months.

According to the company, they spent most of their time in getting recognized for Invossa’s safety by landing in university hospitals and general hospitals for the first 6 months, but the produc...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.